Immunotherapy for metastatic colorectal cancer: Present status and new options. Jan 2012 - :1502-7708 [PMID:22214467] [Ellebaek E] [Andersen MH] [Svane IM] [Straten PT]
Changes in peripheral blood level of regulatory T cells in malignant melanoma patients during treatment with dendritic cell vaccination and low dose IL-2. Jan 2011 - :1365-3083 [PMID:21204893] [Bjoern J] [Brimnes MK] [Andersen MH] [Thor Straten P] [Svane IM]
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial. Apr 2010 - :1477-2566 [PMID:20429791] [Trepiakas R] [Berntsen A] [Hadrup SR] [Bjørn J] [Geertsen PF] [Straten PT] [Andersen MH] [Pedersen AE] [Soleimani A] [Lorentzen T] [Johansen JS] [Svane IM]
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters. Okt 2008 - Cancer Immunol. Immunother.; 58(1):1432-0851 [PMID:18719915] [Engell-Noerregaard L] [Hansen TH] [Andersen MH] [Thor Straten P] [Svane IM]
Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial. Sep 2008 - J. Immunother.; 31(8):1537-4513 [PMID:18779742] [Berntsen A] [Trepiakas R] [Wenandy L] [Geertsen PF] [thor Straten P] [Andersen MH] [Pedersen AE] [Claesson MH] [Lorentzen T] [Johansen JS] [Svane IM]
